Scott Barclay

Scott Barclay is a Managing Director at Insight Partners focused on investments in healthtech. Since joining the firm at the end of 2021, Scott has stretched Insight’s reach into healthcare with investments in mental health companies, healthcare infrastructure platforms, AI healthcare solutions and more. His Computational Care thesis envisions the future of US and global healthcare built at the intersection of empathy and scalable technology. Prior to Insight, Scott built his investing career as a healthcare angel investor and advisor (NaviHealth, Doximity, Elation) and, from 2015 – 2020, as a Partner at DCVC, an early-stage deep tech venture capital firm. Scott’s early career traversed capital markets with Banc of America Securities in Europe and the US, The Boston Consulting Group, and CVS Health. At CVS and then after, Scott helped create and scale the nation’s e-Prescribing ecosystem, running iScribe (acq Allscripts) and as Chief Strategy Officer of Surescripts. Scott holds a BA in History from the University of Virginia and an MBA from INSEAD in Fontainebleau, France.